Trending News

UK will offer under-30s alternative to AZ’s COVID

The UK drugs regulator has said people aged under 30 should be offered an alternative to the AstraZe
Read More

Gilead scores US approval for breast cancer drug t

Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pa
Read More

Healx deploys its AI in hunt for Friedreich’s atax

UK artificial intelligence specialist Healx has begun a partnership with two medical charities that
Read More

Merck’s Keytruda demonstrates adjuvant use in kidn

The interim analysis carried out by an independent data monitoring committee, revealed Keytruda show
Read More

Provention faces delay in FDA review of diabetes p

The issues are holding up discussions between the agency and company about labeling and post-marketi
Read More

Wales forms authority to drive digital health in N

Digital Health and Care Wales (DHCW) – which has emerged from the now defunct NHS Wales Informatics
Read More

Novartis expands in radio-oncology again with $1.3

The collaboration will focus on combining Artios’ DNA damage response (DDR) drug candidates with Nov
Read More


;